“Computer System Improves Pain Therapy for Cancer Patients” (Science)
“Diacetylmorephine Compares Favorably with Methadone” (Elsevier Global Medical News)
Treatment with injectable diacetylmorphine, the active ingredient in heroin, compared favorably with methadone treatment in a phase III clinical trial reported in the Aug. 20 issue of the New England Journal of Medicine.
This is copyright protected information, to receive the full article, please click here to sign up and register.
“GSK’s Hiberix Vaccine Approved, But Is Catch-Up A Sustainable Strategy?” (The Pink Sheet)
“MedCAC Sets October Meeting To Debate AF Catheter Ablation Coverage” (The Gray Sheet)
The Medicare Evidence Development and Coverage Advisory Committee will meet Oct. 21 to see whether evidence shows that treating atrial fibrillation with radiofrequency catheter ablation is safe and effective…
This is copyright protected information, to receive the full article, please click here to sign up and register.
“LaneLabs Harnesses Strong Science, Expert Support To Prevail Over FTC” (The Tan Sheet)
A supplement firm’s victory over the Federal Trade Commission in federal court underscores the rigorous expert support and claim substantiation necessary to thwart legal challenges from regulators…
This is copyright protected information, to receive the full article, please click here to sign up and register.
“FDA Reorganizatoin Elevates Scientific and Food Safety Priorities” (The Pink Sheet)
“ODAC Will Review Denosumab SRE Data if FDA Requires Advisory Committee” (The Pink Sheet)
“Warner Chilcott Acquires P&G’s Global Pharmaceuticals Business” (P&G)
“ADA: No Smiles for Health Reform Bills” (MedPageToday.com)
“FDA Cracks Down on Ibuprofen Skin Creams” (MedPageToday.com)
“http://www.pharmatimes.com/WorldNews/article.aspx?id=16460” (PharmaTimes.com)
“200 western drugs on China’s first essential medicines list” (PharmaTimes.com)
“Analysts mull over possible Teva/Shire/Actelion link-ups” (PharmaTimes.com)
”Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform” (PharmaLive.com)
“FDA Approves Vigabatrin Oral Solution for Treating Infantile Spasms” (MedscapeToday.com)